{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:56:33Z","timestamp":1777301793204,"version":"3.51.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/08585-1"],"award-info":[{"award-number":["2018\/08585-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Project 39-P-4763\/2018"],"award-info":[{"award-number":["Project 39-P-4763\/2018"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.643019\/2021-00"],"award-info":[{"award-number":["88887.643019\/2021-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.512993\/2020-00"],"award-info":[{"award-number":["88887.512993\/2020-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88882.385410\/2019-01"],"award-info":[{"award-number":["88882.385410\/2019-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.643019\/2021-00"],"award-info":[{"award-number":["88887.643019\/2021-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["309802\/2020-2"],"award-info":[{"award-number":["309802\/2020-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11030-021-10371-8","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T05:02:30Z","timestamp":1641618150000},"page":"3365-3378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In silico design and in vitro assessment of anti-Helicobacter pylori compounds as potential small-molecule arginase inhibitors"],"prefix":"10.1007","volume":"26","author":[{"given":"Ana Thereza","family":"Fiori-Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Paulo","family":"de Oliveira Guarnieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Rodrigues Pereira","family":"de Oliveira Borlot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Pereira","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Rezende","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4651-3472","authenticated-orcid":false,"given":"Daniel F\u00e1bio","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"10371_CR1","unstructured":"World Health Organization (WHO) (2017) WHO publishes list of bacteria for which new antibiotics are urgently needed. http:\/\/www.who.int\/mediacentre\/news\/releases\/2017\/bacteria-antibiotics-needed\/en\/. Accessed 1 May 2020"},{"key":"10371_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"10371_CR3","first-page":"1","volume":"10","author":"CW Howden","year":"2014","unstructured":"Howden CW, Chey WD, Vakil NB (2014) Clinical rationale for confirmation testing after treatment of Helicobacter pylori infection: implications of rising antibiotic resistance. Gastroenterol Hepatol 10:1\u201319","journal-title":"Gastroenterol Hepatol"},{"key":"10371_CR4","unstructured":"The Global Cancer Observatory (2020) International agency for research on cancer\u2014IARC. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/7-Stomach-fact-sheet.pdf. Accessed 31 Aug 2021"},{"key":"10371_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrc2857","volume":"10","author":"DB Polk","year":"2010","unstructured":"Polk DB, Peek RM (2010) Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 10:403\u2013414. https:\/\/doi.org\/10.1038\/nrc2857","journal-title":"Nat Rev Cancer"},{"key":"10371_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5114\/pg.2018.80001","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Barsouk A (2019) Epidemiology of gastric cancer: global trends, risk factors and prevention. Gastroenterology Rev 14:26\u201338. https:\/\/doi.org\/10.5114\/pg.2018.80001","journal-title":"Gastroenterology Rev"},{"key":"10371_CR7","doi-asserted-by":"publisher","first-page":"e12738","DOI":"10.1111\/hel.12738","volume":"25","author":"C Schulz","year":"2020","unstructured":"Schulz C, Kup\u010dinskas J (2020) Review\u2014Helicobacter pylori and non-malignant upper gastro-intestinal diseases. Helicobacter 25:e12738. https:\/\/doi.org\/10.1111\/hel.12738","journal-title":"Helicobacter"},{"key":"10371_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrgastro.2016.68","volume":"13","author":"LE Wroblewski","year":"2016","unstructured":"Wroblewski LE, Peek RM (2016) Helicobacter pylori: Pathogenic enablers\u2014toxic relationships in the stomach. Nat Rev Gastroenterol Hepatol 13:317\u2013318. https:\/\/doi.org\/10.1038\/nrgastro.2016.68","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10371_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"WD Chey","year":"2017","unstructured":"Chey WD, Leontiadis GI, Howden CW, Moss SF (2017) ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol 112:212\u2013239. https:\/\/doi.org\/10.1038\/ajg.2016.563","journal-title":"Am J Gastroenterol"},{"key":"10371_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1096\/fj.201900774R","volume":"34","author":"A Chu","year":"2020","unstructured":"Chu A, Wang D, Guo Q et al (2020) Molecular detection of H. pylori antibiotic-resistant genes and molecular docking analysis. FASEB J 34:610\u2013618. https:\/\/doi.org\/10.1096\/fj.201900774R","journal-title":"FASEB J"},{"key":"10371_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.12998\/wjcc.v4.i1.5","volume":"4","author":"M Safavi","year":"2016","unstructured":"Safavi M (2016) Treatment of Helicobacter pylori infection: Current and future insights. World J Clin Cases 4:5\u201319. https:\/\/doi.org\/10.12998\/wjcc.v4.i1.5","journal-title":"World J Clin Cases"},{"key":"10371_CR12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V et al (2016) Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther 43:514\u2013533. https:\/\/doi.org\/10.1111\/apt.13497","journal-title":"Aliment Pharmacol Ther"},{"key":"10371_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK et al (2017) Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153:420\u2013429. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.022","journal-title":"Gastroenterology"},{"key":"10371_CR14","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.4049\/jimmunol.168.9.4692","volume":"168","author":"AP Gobert","year":"2002","unstructured":"Gobert AP, Cheng Y, Wang J-Y et al (2002) Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol 168:4692\u20134700. https:\/\/doi.org\/10.4049\/jimmunol.168.9.4692","journal-title":"J Immunol"},{"key":"10371_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","volume":"23","author":"LE Wroblewski","year":"2010","unstructured":"Wroblewski LE, Peek RM, Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23:713\u2013739. https:\/\/doi.org\/10.1128\/CMR.00011-10","journal-title":"Clin Microbiol Rev"},{"key":"10371_CR16","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.4049\/jimmunol.168.12.6002","volume":"168","author":"AP Gobert","year":"2002","unstructured":"Gobert AP, Mersey BD, Cheng Y et al (2002) Cutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J Immunol 168:6002\u20136006. https:\/\/doi.org\/10.4049\/jimmunol.168.12.6002","journal-title":"J Immunol"},{"key":"10371_CR17","doi-asserted-by":"publisher","first-page":"13844","DOI":"10.1073\/pnas.241443798","volume":"98","author":"AP Gobert","year":"2001","unstructured":"Gobert AP, McGee DJ, Akhtar M et al (2001) Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 98:13844\u201313849. https:\/\/doi.org\/10.1073\/pnas.241443798","journal-title":"Proc Natl Acad Sci USA"},{"key":"10371_CR18","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.2174\/1568026619666191112105650","volume":"19","author":"RP Rodrigues","year":"2020","unstructured":"Rodrigues RP, Ardisson JS, Gon\u00e7alves RDCR et al (2020) Search for potential inducible nitric oxide synthase inhibitors with favorable ADMET profiles for the therapy of Helicobacter pylori infections. Curr Top Med Chem 19:2795\u20132804. https:\/\/doi.org\/10.2174\/1568026619666191112105650","journal-title":"Curr Top Med Chem"},{"key":"10371_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0929867326666190301143549","volume":"26","author":"AT Fiori-Duarte","year":"2019","unstructured":"Fiori-Duarte AT, Rodrigues RP, Kitagawa RR, Kawano DF (2019) Insights into the design of inhibitors of the urease enzyme\u2014a major target for the treatment of Helicobacter pylori infections. Curr Med Chem 26:1\u201315. https:\/\/doi.org\/10.2174\/0929867326666190301143549","journal-title":"Curr Med Chem"},{"key":"10371_CR20","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1042\/BCJ20190545","volume":"476","author":"A Dutta","year":"2019","unstructured":"Dutta A, Mazumder M, Alam M et al (2019) Metal-induced change in catalytic loop positioning in Helicobacter pylori arginase alters catalytic function. Biochem J 476:3595\u20133614. https:\/\/doi.org\/10.1042\/BCJ20190545","journal-title":"Biochem J"},{"key":"10371_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/med.21419","volume":"37","author":"M Pudlo","year":"2017","unstructured":"Pudlo M, Demougeot C, Girard-Thernier C (2017) Arginase inhibitors: a rational approach over one century: an exhaustive review of arginase inhibitors. Med Res Rev 37:475\u2013513. https:\/\/doi.org\/10.1002\/med.21419","journal-title":"Med Res Rev"},{"key":"10371_CR22","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/iub.401","volume":"62","author":"A Srivastava","year":"2010","unstructured":"Srivastava A, Sau AK (2010) Biochemical studies on Helicobacter pylori arginase: Insight into the difference in activity compared to other arginases. IUBMB Life 62:906\u2013915. https:\/\/doi.org\/10.1002\/iub.401","journal-title":"IUBMB Life"},{"key":"10371_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jmgm.2009.12.007","volume":"28","author":"H Azizian","year":"2010","unstructured":"Azizian H, Bahrami H, Pasalar P, Amanlou M (2010) Molecular modeling of Helicobacter pylori arginase and the inhibitor coordination interactions. J Mol Graph Model 28:626\u2013635. https:\/\/doi.org\/10.1016\/j.jmgm.2009.12.007","journal-title":"J Mol Graph Model"},{"key":"10371_CR24","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-L\u00f3pez E, Barrientos-Salcedo C, Prieto-Mart\u00ednez FD, Medina-Franco JL (2020) In silico tools to study molecular targets of neglected diseases: inhibition of TcSir2rp3, an epigenetic enzyme of Trypanosoma cruzi. In: Advances in protein chemistry and structural biology. Elsevier, pp 203\u2013229. https:\/\/doi.org\/10.1016\/bs.apcsb.2020.04.001","DOI":"10.1016\/bs.apcsb.2020.04.001"},{"key":"10371_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM (2000) The Protein Data Bank. Nucleic Acids Res 28:235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"10371_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2180-7-26","volume":"7","author":"JG Hovey","year":"2007","unstructured":"Hovey JG, Watson EL, Langford ML et al (2007) Genetic microheterogeneity and phenotypic variation of Helicobacter pylori arginase in clinical isolates. BMC Microbiol 7:26. https:\/\/doi.org\/10.1186\/1471-2180-7-26","journal-title":"BMC Microbiol"},{"key":"10371_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/0471721204","volume-title":"Structural bioinformatics","author":"PE Bourne","year":"2003","unstructured":"Bourne PE, Weissig H (2003) Structural bioinformatics. Wiley-Liss, New Jersey"},{"key":"10371_CR28","doi-asserted-by":"publisher","first-page":"5.6.1","DOI":"10.1002\/0471250953.bi0506s15","volume":"15","author":"N Eswar","year":"2006","unstructured":"Eswar N, Webb B, Marti-Renom MA et al (2006) Comparative Protein Structure Modeling Using Modeller. Curr Protoc Bioinformatics 15:5.6.1-5.6.30. https:\/\/doi.org\/10.1002\/0471250953.bi0506s15","journal-title":"Curr Protoc Bioinformatics"},{"key":"10371_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283\u2013291. https:\/\/doi.org\/10.1107\/S0021889892009944","journal-title":"J Appl Crystallogr"},{"key":"10371_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1471-2105-15-197","volume":"15","author":"SH Oliveira","year":"2014","unstructured":"Oliveira SH, Ferraz FA, Honorato RV et al (2014) KVFinder: steered identification of protein cavities as a PyMOL plugin. BMC Bioinform 15:197. https:\/\/doi.org\/10.1186\/1471-2105-15-197","journal-title":"BMC Bioinform"},{"key":"10371_CR31","volume-title":"Discovery studio visualizer (DSV) v4.0.100.13345","author":"A Basu","year":"2013","unstructured":"Basu A et al (2013) Discovery studio visualizer (DSV) v4.0.100.13345. ACCELRYS, San Diego"},{"key":"10371_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10822-007-9163-6","volume":"22","author":"J Kirchmair","year":"2008","unstructured":"Kirchmair J, Markt P, Distinto S et al (2008) Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection\u2014What can we learn from earlier mistakes? J Comput Aided Mol Des 22:213\u2013228. https:\/\/doi.org\/10.1007\/s10822-007-9163-6","journal-title":"J Comput Aided Mol Des"},{"key":"10371_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul SF, Gish W, Miller W et al (1990) Basic local alignment search tool. J Mol Biol 215:403\u2013410. https:\/\/doi.org\/10.1016\/S0022-2836(05)80360-2","journal-title":"J Mol Biol"},{"key":"10371_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0167-4838(98)00207-6","volume":"1388","author":"GL Mendz","year":"1998","unstructured":"Mendz GL, Holmes EM, Ferrero RL (1998) In situ characterization of Helicobacter pylori arginase. Biochim Biophys Acta 1388:465\u2013477. https:\/\/doi.org\/10.1016\/S0167-4838(98)00207-6","journal-title":"Biochim Biophys Acta"},{"key":"10371_CR35","doi-asserted-by":"publisher","first-page":"8987","DOI":"10.1021\/bi0491705","volume":"43","author":"E Cama","year":"2004","unstructured":"Cama E, Pethe S, Boucher J-L et al (2004) Inhibitor coordination interactions in the binuclear manganese cluster of arginase. Biochemistry 43:8987\u20138999. https:\/\/doi.org\/10.1021\/bi0491705","journal-title":"Biochemistry"},{"key":"10371_CR36","doi-asserted-by":"publisher","first-page":"e26205","DOI":"10.1371\/journal.pone.0026205","volume":"6","author":"J Zhang","year":"2011","unstructured":"Zhang J, Zhang X, Wu C et al (2011) Expression, purification and characterization of arginase from Helicobacter pylori in Its Apo Form. PLoS ONE 6:e26205. https:\/\/doi.org\/10.1371\/journal.pone.0026205","journal-title":"PLoS ONE"},{"key":"10371_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1107\/S2053230X16003630","volume":"72","author":"Y Hai","year":"2016","unstructured":"Hai Y, Christianson DW (2016) Crystal structures of Leishmania mexicana arginase complexed with \u03b1, \u03b1-disubstituted boronic amino-acid inhibitors. Acta Crystallogr F Struct Biol Commun 72:300\u2013306. https:\/\/doi.org\/10.1107\/S2053230X16003630","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"10371_CR38","doi-asserted-by":"publisher","first-page":"W636","DOI":"10.1093\/nar\/gkz268","volume":"47","author":"F Madeira","year":"2019","unstructured":"Madeira F, Park Y, mi, Lee J, et al (2019) The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res 47:W636\u2013W641. https:\/\/doi.org\/10.1093\/nar\/gkz268","journal-title":"Nucleic Acids Res"},{"key":"10371_CR39","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, JohnJ I, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55:6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"key":"10371_CR40","unstructured":"Thompson MA (2004) Molecular docking using arguslab, an efficient shape-based search algorithm and the ascore scoring function. Philadelphia: ACS meeting 172"},{"key":"10371_CR41","unstructured":"MarvinSketch v19.25. (2019) ChemAxon Ltd., Budapest. http:\/\/www.chemaxon.com"},{"key":"10371_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC et al (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727\u2013748. https:\/\/doi.org\/10.1006\/jmbi.1996.0897","journal-title":"J Mol Biol"},{"key":"10371_CR43","unstructured":"Sigma-Aldrich (2010) Selected structure sets. In: Sigma aldrich. http:\/\/www.sigmaaldrich.com\/chemistry\/chemistry-services\/selected-structure.html. Accessed 10 Sep 2017"},{"key":"10371_CR44","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1021\/jm200590k","volume":"54","author":"T Huhtiniemi","year":"2011","unstructured":"Huhtiniemi T, Salo HS, Suuronen T et al (2011) Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2. J Med Chem 54:6456\u20136468. https:\/\/doi.org\/10.1021\/jm200590k","journal-title":"J Med Chem"},{"key":"10371_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.15761\/CPB.1000113","volume":"1","author":"NR Gacche","year":"2016","unstructured":"Gacche NR, Meshram JR, Dawane AA et al (2016) Modeling studies of arginase from Helicobacter pylori divulge novel inhibitor-protein interactions. Clin Proteom Bioinform 1:54\u201361. https:\/\/doi.org\/10.15761\/CPB.1000113","journal-title":"Clin Proteom Bioinform"},{"key":"10371_CR46","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.biocel.2013.02.008","volume":"45","author":"X Zhang","year":"2013","unstructured":"Zhang X, Zhang J, Zhang R et al (2013) Structural, enzymatic and biochemical studies on Helicobacter pylori arginase. Int J Biochem Cell Biol 45:995\u20131002. https:\/\/doi.org\/10.1016\/j.biocel.2013.02.008","journal-title":"Int J Biochem Cell Biol"},{"key":"10371_CR47","doi-asserted-by":"publisher","first-page":"W665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: an automated pipeline for the setup of Poisson\u2013Boltzmann electrostatics calculations. Nucleic Acids Res 32:W665\u2013W667. https:\/\/doi.org\/10.1093\/nar\/gkh381","journal-title":"Nucleic Acids Res"},{"key":"10371_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0022-2836(02)00777-5","volume":"322","author":"BQ Wei","year":"2002","unstructured":"Wei BQ, Baase WA, Weaver LH et al (2002) A model binding site for testing scoring functions in molecular docking. J Mol Biol 322:339\u2013355. https:\/\/doi.org\/10.1016\/S0022-2836(02)00777-5","journal-title":"J Mol Biol"},{"key":"10371_CR49","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/prot.10465","volume":"52","author":"ML Verdonk","year":"2003","unstructured":"Verdonk ML, Cole JC, Hartshorn MJ et al (2003) Improved protein-ligand docking using GOLD. Proteins 52:609\u2013623. https:\/\/doi.org\/10.1002\/prot.10465","journal-title":"Proteins"},{"key":"10371_CR50","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/00498250600861660","volume":"36","author":"S Ekins","year":"2006","unstructured":"Ekins S, Bugrim A, Brovold L et al (2006) Algorithms for network analysis in systems-ADME\/Tox using the MetaCore and MetaDrug platforms. Xenobiotica 36:877\u2013901. https:\/\/doi.org\/10.1080\/00498250600861660","journal-title":"Xenobiotica"},{"key":"10371_CR51","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/17460441.2019.1581170","volume":"14","author":"E L\u00f3pez-L\u00f3pez","year":"2019","unstructured":"L\u00f3pez-L\u00f3pez E, Naveja JJ, Medina-Franco JL (2019) DataWarrior: an evaluation of the open-source drug discovery tool. Expert Opin Drug Discov 14:335\u2013341. https:\/\/doi.org\/10.1080\/17460441.2019.1581170","journal-title":"Expert Opin Drug Discov"},{"key":"10371_CR52","unstructured":"Cockerill FR, Clinical and Laboratory Standards Institute (2012) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. Clinical and Laboratory Standards Institute, Wayne"},{"key":"10371_CR53","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.tiv.2009.06.017","volume":"23","author":"PF Freire","year":"2009","unstructured":"Freire PF, Peropadre A, Mart\u00edn JMP et al (2009) An integrated cellular model to evaluate cytotoxic effects in mammalian cell lines. Toxicol in Vitro 23:1553\u20131558. https:\/\/doi.org\/10.1016\/j.tiv.2009.06.017","journal-title":"Toxicol in Vitro"},{"key":"10371_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"},{"key":"10371_CR55","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1021\/ci600426e","volume":"47","author":"J-F Truchon","year":"2007","unstructured":"Truchon J-F, Bayly CI (2007) Evaluating virtual screening methods: good and bad metrics for the \u201cearly recognition\u201d problem. J Chem Inf Model 47:488\u2013508. https:\/\/doi.org\/10.1021\/ci600426e","journal-title":"J Chem Inf Model"},{"key":"10371_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2105-10-58","volume":"10","author":"H Li","year":"2009","unstructured":"Li H, Zhang H, Zheng M et al (2009) An effective docking strategy for virtual screening based on multi-objective optimization algorithm. BMC Bioinform 10:58. https:\/\/doi.org\/10.1186\/1471-2105-10-58","journal-title":"BMC Bioinform"},{"key":"10371_CR57","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1021\/jm049092j","volume":"48","author":"N Triballeau","year":"2005","unstructured":"Triballeau N, Acher F, Brabet I et al (2005) Virtual screening workflow development guided by the \u201creceiver operating characteristic\u201d curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 48:2534\u20132547. https:\/\/doi.org\/10.1021\/jm049092j","journal-title":"J Med Chem"},{"key":"10371_CR58","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1021\/ci034289q","volume":"44","author":"ML Verdonk","year":"2004","unstructured":"Verdonk ML, Berdini V, Hartshorn MJ et al (2004) Virtual screening using protein\u2212ligand docking: avoiding artificial enrichment. J Chem Inf Comput Sci 44:793\u2013806. https:\/\/doi.org\/10.1021\/ci034289q","journal-title":"J Chem Inf Comput Sci"},{"key":"10371_CR59","doi-asserted-by":"publisher","unstructured":"Deb PK, Abed SN, Jaber AMY, Tekade RK (2018) Particulate level properties and its implications on product performance and processing. In: Dosage form design parameters. Elsevier, pp 155\u2013220. https:\/\/doi.org\/10.1016\/B978-0-12-409547-2.12318-2","DOI":"10.1016\/B978-0-12-409547-2.12318-2"},{"key":"10371_CR60","doi-asserted-by":"publisher","unstructured":"Yan Z, Wang J (2016)\u00a0Scoring functions of protein-ligand interactions. In: Methods and algorithms for molecular docking-based drug design and discovery. IGI Global, pp 220\u2013245. https:\/\/doi.org\/10.4018\/978-1-5225-0115-2.ch009","DOI":"10.4018\/978-1-5225-0115-2.ch009"},{"key":"10371_CR61","doi-asserted-by":"publisher","unstructured":"Chen H, Zhou X, Gao Y, et al (2017) Fragment-based drug design: strategic advances and lessons learned. In: Comprehensive medicinal chemistry III. Elsevier, pp 212\u2013232. https:\/\/doi.org\/10.1016\/B978-0-12-409547-2.12319-4","DOI":"10.1016\/B978-0-12-409547-2.12319-4"},{"key":"10371_CR62","doi-asserted-by":"publisher","unstructured":"Holdgate GA (2017) Kinetics, thermodynamics, and ligand efficiency metrics in drug discovery. In:\u00a0Chemistry, molecular sciences and chemical engineering. Elsevier, pp 180\u2013211.\u00a0https:\/\/doi.org\/10.1016\/B978-0-12-409547-2.12318-2","DOI":"10.1016\/B978-0-12-409547-2.12318-2"},{"key":"10371_CR63","doi-asserted-by":"publisher","first-page":"10368","DOI":"10.3748\/wjg.v20.i30.10368","volume":"20","author":"Y-C Wang","year":"2014","unstructured":"Wang Y-C (2014) Medicinal plant activity on Helicobacter pylori related diseases. World J Gastroentero 20:10368. https:\/\/doi.org\/10.3748\/wjg.v20.i30.10368","journal-title":"World J Gastroentero"},{"key":"10371_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168944","volume":"12","author":"J-T Zhou","year":"2017","unstructured":"Zhou J-T, Li C-L, Tan L-H et al (2017) Inhibition of Helicobacter pylori and its associated urease by palmatine: investigation on the potential mechanism. PLoS ONE 12:e0168944. https:\/\/doi.org\/10.1371\/journal.pone.0168944","journal-title":"PLoS ONE"},{"key":"10371_CR65","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/microorganisms8040503","volume":"8","author":"A Gonz\u00e1lez","year":"2020","unstructured":"Gonz\u00e1lez A, Casado J, Chueca E et al (2020) Small molecule inhibitors of the response regulator ArsR exhibit bactericidal activity against Helicobacter pylori. Microorganisms 8:503. https:\/\/doi.org\/10.3390\/microorganisms8040503","journal-title":"Microorganisms"},{"key":"10371_CR66","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1039\/C5RA23477H","volume":"6","author":"S Ghosh","year":"2016","unstructured":"Ghosh S, Chakraborty P, Chakrabarti A et al (2016) Biological activity of dendrimer\u2013methylglyoxal complexes for improved therapeutic efficacy against malignant cells. RSC Adv 6:6631\u20136642. https:\/\/doi.org\/10.1039\/C5RA23477H","journal-title":"RSC Adv"},{"key":"10371_CR67","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1021\/ci700404c","volume":"48","author":"XS Wang","year":"2008","unstructured":"Wang XS, Tang H, Golbraikh A, Tropsha A (2008) Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F. J Chem Inf Model 48:997\u20131013. https:\/\/doi.org\/10.1021\/ci700404c","journal-title":"J Chem Inf Model"},{"key":"10371_CR68","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jcmgh.2016.12.001","volume":"3","author":"SF Moss","year":"2017","unstructured":"Moss SF (2017) The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol 3:183\u2013191. https:\/\/doi.org\/10.1016\/j.jcmgh.2016.12.001","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10371_CR69","doi-asserted-by":"publisher","first-page":"7902","DOI":"10.18632\/oncotarget.24083","volume":"9","author":"E Cho","year":"2018","unstructured":"Cho E, Lee J-K, Park E et al (2018) Antitumor activity of HPA3P through RIPK3-dependent regulated necrotic cell death in colon cancer. Oncotarget 9:7902\u20137917. https:\/\/doi.org\/10.18632\/oncotarget.24083","journal-title":"Oncotarget"},{"key":"10371_CR70","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/jnci\/91.3.215","volume":"91","author":"SD Hursting","year":"1999","unstructured":"Hursting SD, Slaga TJ, Fischer SM et al (1999) Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst 91:215\u2013225. https:\/\/doi.org\/10.1093\/jnci\/91.3.215","journal-title":"J Natl Cancer Inst"},{"key":"10371_CR71","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1158\/1940-6207.CAPR-12-0369","volume":"6","author":"T Niwa","year":"2013","unstructured":"Niwa T, Toyoda T, Tsukamoto T et al (2013) Prevention of Helicobacter pylori\u2014induced gastric cancers in gerbils by a DNA demethylating agent. Cancer Prev Res 6:263\u2013270. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-12-0369","journal-title":"Cancer Prev Res"},{"key":"10371_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1749-8546-7-15","volume":"7","author":"N Weerapreeyakul","year":"2012","unstructured":"Weerapreeyakul N, Nonpunya A, Barusrux S et al (2012) Evaluation of the anticancer potential of six herbs against a hepatoma cell line. Chin Med 7:15. https:\/\/doi.org\/10.1186\/1749-8546-7-15","journal-title":"Chin Med"},{"key":"10371_CR73","first-page":"2993","volume":"29","author":"RB Badisa","year":"2009","unstructured":"Badisa RB, Darling-Reed SF, Joseph P et al (2009) Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells. Anticancer Res 29:2993\u20132996","journal-title":"Anticancer Res"},{"key":"10371_CR74","unstructured":"Clarivate Metacore online. In: Clarivate. https:\/\/portal.genego.com\/help2\/wwhelp\/wwhimpl\/js\/html\/wwhelp.htm. Accessed 10 Nov 2021"},{"key":"10371_CR75","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.drudis.2009.07.014","volume":"14","author":"TJ Ritchie","year":"2009","unstructured":"Ritchie TJ, Macdonald SJF (2009) The impact of aromatic ring count on compound developability \u2013 are too many aromatic rings a liability in drug design? Drug Discov Today 14:1011\u20131020. https:\/\/doi.org\/10.1016\/j.drudis.2009.07.014","journal-title":"Drug Discov Today"},{"key":"10371_CR76","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1021\/ci00024a602","volume":"35","author":"D Bloch","year":"1995","unstructured":"Bloch D (1995) Computer software review. Review of PHYSPROP database (Version 1.0). J Chem Inf Comput Sci 35:328\u2013329. https:\/\/doi.org\/10.1021\/ci00024a602","journal-title":"J Chem Inf Comput Sci"},{"key":"10371_CR77","unstructured":"openmolecules.org (2021) DataWarrior User Manual. In: openmolecules.org. https:\/\/openmolecules.org\/properties\/properties.html#psa. Accessed 20 Nov 2021"},{"key":"10371_CR78","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrd.2017.146","volume":"16","author":"AM Davis","year":"2017","unstructured":"Davis AM, Plowright AT, Valeur E (2017) Directing evolution: the next revolution in drug discovery? Nat Rev Drug Discov 16:681\u2013698. https:\/\/doi.org\/10.1038\/nrd.2017.146","journal-title":"Nat Rev Drug Discov"},{"key":"10371_CR79","volume-title":"Drug-like properties: concepts, structure design and methods: from ADME to toxicity optimization","author":"EH Kerns","year":"2008","unstructured":"Kerns EH, Di L (2008) Drug-like properties: concepts, structure design and methods: from ADME to toxicity optimization. Academic Press, Amsterdam"},{"key":"10371_CR80","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-2272-7_3","volume-title":"Site-specific protein labeling","author":"NJ Yang","year":"2015","unstructured":"Yang NJ, Hinner MJ (2015) Getting across the cell membrane: an overview for small molecules, peptides, and proteins. In: Gautier A, Hinner MJ (eds) Site-specific protein labeling. Springer, New York, pp 29\u201353. https:\/\/doi.org\/10.1007\/978-1-4939-2272-7_3"},{"key":"10371_CR81","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/pharmacy6020043","volume":"6","author":"A Fuentes","year":"2018","unstructured":"Fuentes A, Pineda M, Venkata K (2018) Comprehension of Top 200 prescribed drugs in the US as a resource for pharmacy teaching. Train Pract Pharm 6:43. https:\/\/doi.org\/10.3390\/pharmacy6020043","journal-title":"Train Pract Pharm"},{"key":"10371_CR82","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jmb.2006.09.039","volume":"364","author":"C-W Chiang","year":"2006","unstructured":"Chiang C-W, Yeh H-C, Wang L-H, Chan N-L (2006) Crystal structure of the human prostacyclin synthase. J Mol Biol 364:266\u2013274. https:\/\/doi.org\/10.1016\/j.jmb.2006.09.039","journal-title":"J Mol Biol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10371-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-021-10371-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10371-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T16:29:08Z","timestamp":1667579348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-021-10371-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10371"],"URL":"https:\/\/doi.org\/10.1007\/s11030-021-10371-8","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]},"assertion":[{"value":"7 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}